[PDF] Top 20 The MS Disease- Modifying Medications
Has 10000 "The MS Disease- Modifying Medications" found on our website. Below are the top 20 most common "The MS Disease- Modifying Medications".
The MS Disease- Modifying Medications
... clinical trial developed progressive multifocal leukoencephalophy (PML -- see p. 20) after the trial ended, and died. PML typically occurs only in people whose ability to fight infection has been severely reduced. Among ... See full document
17
The Changing Face of Multiple Sclerosis and Disease-modifying Therapies
... regular blood tests are recommended. IFNs may also increase the risk for depression, so precautions and agressive treatment of depression are recommended. Avonex and Rebif are available in pre-filled syringes that do not ... See full document
6
Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis
... models were used to analyze each of the following: 1) the impact of route of administration (oral or injectable) on adherence to the index DMT; 2) the impact of adherence on likelihood of MS relapse; and 3) the ... See full document
10
Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS
... with MS are receiving DMDs prior to preg- ...with MS who are considering pregnancy or those who are pregnant and their health care professionals with information on other patients’ experiences of care, the ... See full document
10
Adherence to disease-modifying therapies in patients with multiple sclerosis
... ence in chronic diseases as one of the most important com- ponents of therapeutic management. Therefore, conducting further studies to determine the degree of adherence among MS patients is extremely important in ... See full document
10
Comment on 2018 American Academy of Neurology guidelines on disease-modifying therapies in MS
... recent disease activity, age, MRI burden of disease, comorbidities, or other factors known to affect disease ...progressive MS, and establishing the presence and magnitude of long-term benefits ... See full document
8
Discontinuation of Disease-Modifying Treatment for Multiple Sclerosis
... in MS can be improved by using prospective, population-based designs with appropriate comparators and standardized data collection ...long-term disease presence, since the two ... See full document
126
Lifestyle, medication and socio-demographic determinants of mental and physical health-related quality of life in people with multiple sclerosis
... in MS [13, 14], particularly depression and fatigue [15, 16], there has been little research on associations of lifestyle and socio- demographic factors with physical and mental ...with MS on the relative ... See full document
9
Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients
... of MS patients are diagnosed with relapsing-remitting multiple sclerosis (RRMS) and ex- perience clearly defined disease exacerbations that last from a few hours to months [4, ...from disease ... See full document
11
Motivations for inadequate persistence with disease modifying anti rheumatic drugs in early rheumatoid arthritis: the patient’s perspective
... and disease factors ...his medications in Japanese patients [29] and this strategy could be intensified in order to improve compli- ...and disease activity ... See full document
8
Disease Modifying Anti-rheumatic Drugs (DMARDs)
... of disease progression as there were initial questions regarding toxicity and ...these medications safe and effective for use in children but also that its use early in the course of the disease may ... See full document
7
Patient perspectives on switching disease-modifying therapies in the NARCOMS registry
... MHRC, MS Society of Canada, MS Scientific Research Foundation, CMSC Foundation, and Rx & D Health Research ...National MS Society, and receives consulting or speaking fees from Alexion, Accentia, ... See full document
9
Outcome of MS relapses in the era of disease-modifying therapy
... of MS patients who require the most efficient relapse ...medical MS ma- nagement, rather than relying on patients to return if unsatisfied, will – in our opinion - raise patients’ expec- tations towards ... See full document
8
- Note the recent developments with, and future plans for, the UK MS Clinical Trials Network
... the MS Society established the UK MS Clinical Trials Network (CTN) and tasked the Network with planning and conducting a large scale clinical trial for progressive ...no disease modifying ... See full document
6
Management of Inflammatory Arthritis in pregnancy: a National Cross-Sectional Survey of Canadian rheumatologists
... azathioprine, and sulfasalazine. Regarding biologics/small molecules, the EULAR guidance support use of anti-TNFs during the start of pregnancy, with certolizumab and etanercept use being acceptable throughout pregnancy ... See full document
9
Surprising natural treatment for alzheimer's disease: coconut oil
... Coconut Oil: Thismay offer profound benefits in the fight against Alzheimer’s disease. One of the primary fuels your brain uses is glucose, which is converted into energy. When your brain becomes insulin ... See full document
8
Analysis of Technological Developments in the Treatment of Alzheimer’s Disease through Patent Documents
... Alzheimer’s disease treat- ment has risen in line with the growth in the number of cases around the ...daily medications for 20 years or longer, the drug industry has every interest in researching it [24] ... See full document
14
Translational research in Huntington’s disease: opening up for disease modifying treatment
... The typical presentation of HD is the development of sub- tle cognitive and behavioural changes with involuntary, hyperkinetic, choreatic movements at around 40 years old. In the case of a dominant phenotype with a ... See full document
6
Medications used in chronic obstructive pulmonary disease
... pulmonary disease (COPD) is smoking and can be stopped to avoid the disease, regardless of the major cause of other diseases, nicotine replacement, by the use of nicotine stick, milk, tablets or capsules, ... See full document
5
The early diagnosis of alzheimer’s disease using deep learning
... The other study looked at PET scans using fluorine 18-labeled flutemetamol tracer among seven people with normal pressure hydrocephalus, a progressive condition that causes dementia and often mimics Alzheimer's ... See full document
9
Related subjects